🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
2.740
-0.145 (-5.03%)
At close: Nov 20, 2026, 4:00 PM EST
2.730
-0.010 (-0.36%)
After-hours: Nov 20, 2026, 7:30 PM EST

Verrica Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
14.3930.1546.3369.5534.2715.75
Short-Term Investments
-----54.6
Cash & Short-Term Investments
14.3930.1546.3369.5534.2770.35
Cash Growth
-31.77%-34.93%-33.38%102.92%-51.29%7.46%
Receivables
11.655.40.084.420.49-
Inventory
2.82.242.461.02--
Prepaid Expenses
3.732.82.312.554.363.97
Other Current Assets
3.821.96----
Total Current Assets
36.442.5451.1877.5339.1274.33
Property, Plant & Equipment
2.541.862.583.625.335.5
Other Long-Term Assets
0.922.730.380.450.280.3
Total Assets
39.8647.1354.1381.644.7280.13

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
-2.071.92.460.510.85
Accrued Expenses
-4.033.098.172.433.01
Short-Term Debt
-----41.69
Current Portion of Long-Term Debt
--12.94---
Current Portion of Leases
-0.750.670.70.30.25
Current Unearned Revenue
-0.78----
Other Current Liabilities
19.268.8110.425.690.220.26
Total Current Liabilities
19.2616.4429.0117.023.4646.06
Long-Term Debt
11.64-30.9842.87--
Long-Term Leases
-0.891.351.941.231.47
Other Long-Term Liabilities
14.945.072.65---
Total Liabilities
45.8422.3963.9961.834.6947.52

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
-5.9700000
Additional Paid-In Capital
-349.65297.17250.21203.48171.6
Retained Earnings
--324.91-307.03-230.45-163.45-138.97
Comprehensive Income & Other
------0.03
Total Common Equity
-5.9724.74-9.8619.7640.0332.61
Shareholders' Equity
-5.9724.74-9.8619.7640.0332.61
Total Liabilities & Equity
39.8647.1354.1381.644.7280.13

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
11.641.6345.9445.511.5343.41
Net Cash (Debt)
2.7628.520.3924.0432.7526.95
Net Cash Growth
-7211.79%-98.38%-26.60%21.53%-4.67%
Net Cash Per Share
0.142.680.085.309.599.96
Filing Date Shares Outstanding
21.3117.189.184.244.192.75
Total Common Shares Outstanding
21.3117.189.184.244.112.75
Working Capital
17.1426.122.1760.5135.6628.27
Book Value Per Share
-0.281.44-1.074.669.7411.85
Tangible Book Value
-5.9724.74-9.8619.7640.0332.61
Tangible Book Value Per Share
-0.281.44-1.074.669.7411.85
Machinery
-1.211.792.1721.37
Construction In Progress
----2.542.73
Leasehold Improvements
-0.050.050.050.050.05
SEC Filings: 10-K · 10-Q